The Sackler family got richer than the Rockefellers by marketing Oxycontin in ways that kickstarted the global opioid epidemic, whose body count continues to rise -- more than 200,000 dead in the US alone, which is more Americans than died in the Vietnam war.

The Sacklers aren’t just as rich as a Gilded Age looter, they’ve also absorbed the Gilded Age tactic of fractioning off relatively piddling sums and giving them to cultural institutions as Exhibit A in the modern practice of looter reputation-laundering.

But given the incredible death toll from opioids and leaks of sealed court documents that show the Sacklers’ complicity in those deaths, institutions are starting to break ties with the family, helped along by artists like opioid survivor Nan Goldin, whose massive, mediagenic protest actions inside of galleries and museums have gone a long way to showing institutions that their Sackler wing is a very bad look indeed.

The latest casualty seems to be the Louvre in Paris. Shortly after Goldin staged an action outside of the museum, the museum’s board of directors suddenly remembered that they have a policy of removing endowment thank-yous after 20 years, and it had been 22 years since the Sacklers paid to have their names plastered all over the place. Now, every mention of the Sackler name has been purged from the institution, down to the smallest signs, which have been covered over with tape.

The Louvre officially says that it was just enforcing its policies and it’s nothing personal about the Sacklers, but they couldn’t explain why they only remembered that they had these policies after Goldin called them to account in a public, showy way.

The Louvre museum’s president, Jean-Luc Martinez, told French radio station RTL that there is a 20-year limit on naming rights and the Sackler donation for the wing was in 1997. He did not explain why it had taken more than two years to remove the signs.

Martinez would also not reveal exactly when the name had been removed. However, it is thought to have been covered up when the wing was closed to visitors for a few days in the second week of July.

The move follows protests on July 1 led by the activist Nan Goldin, a former opioid addict, demanding the Sackler name be removed from the Louvre over accusations the family has profited from their company’s highly addictive painkiller Oxycontin.

Louvre Removes Sackler Family Name From Its Walls [Alex Marshall/New York Times]

Louvre removes Sackler name amid controversy over opioid crisis [Sophie Gorman/France 24]

(via Naked Capitalism)

Related Articles:

Dr Jeffrey Bado received his first sales visit from a Purdue Pharma representative in September 2005. In the next five years, his prescriptions of OxyContin – the “jet fuel” of America’s opioid crisis, according to Pennsylvania’s attorney general – increased by 600%, as Purdue reps visited two to three times a week. Now, a lawsuit in the state seeks to hold the company accountable.

A doctor who led the charge for mass prescribing of opioids in the US, and was then paid by Purdue Pharma to help drive sales of OxyContin, is to testify against the drugmaker and other companies facing a raft of lawsuits over America’s opioid epidemic.

The maker of OxyContin has reached a settlement with the state of Oklahoma over the prescription painkiller's role in the nation's deadly opioid crisis, officials said on Tuesday... Individuals familiar with the matter said that Purdue Pharma LP and members of the Sackler family who own the company reached a $270m settlement, Reuters reported. 

A group made up of more than 500 cities, counties and Native American tribes across the United States has filed a massive lawsuit accusing members of the Sackler family, who own the maker of the opioid painkiller OxyContin, of helping to create “the worst drug crisis in American history”.

As backlash against America's painkiller addiction grows, gedge fund Hildene Capital Management has cut ties with the billionaire family that controls the OxyContin maker Purdue Pharma. According to The Wall Street Journal, Hildene fund manager Brett Jefferson forced the Sackler family who is invested in the $10 billion fund to start redeeming their investments.

In May 1997, the year after Purdue Pharma launched OxyContin, its head of sales and marketing sought input on a key decision from Dr. Richard Sackler, a member of the billionaire family that founded and controls the company. Michael Friedman told Sackler that he didn’t want to correct the false impression among doctors that OxyContin was weaker than morphine, because the myth was boosting prescriptions — and sales.

The Massachusetts attorney general is targeting Purdue Pharma and eight members of the Sackler family who own the company, alleging in a lawsuit they are "personally responsible" for deceptively selling OxyContin. 

A member of the family that owns Purdue Pharma — which is being sued by more than 1,000 jurisdictions for its alleged role in seeding the opioid crisis with its pain medication OxyContin — has been awarded a patent for a treatment for opioid use disorder.